Hi, do keep in mind context is important here, the cost saving figure is not just a market announcement for shareholders. It's an independent economic study to influence insurers in adopting our CPT code & identifying the best test price points. This was mentioned in Eurozs coverage report. Renalytix undertook exactly the same study for their KidneyIntelX test & also used the same independent firm (Boston Healthcare).This study is not a promotional piece, but a key part of the path forward for the commercialization pathway. Lots of new folks on the boards recently, I recommend people read the latest Euroz report to get up to speed. If you want a copy, let me know. Some folk pointing concerns to the lack of market adoption but forget we have been in a global pandemic for the last 1.5years & still working towards a IVD test.
PIQ Price at posting:
92.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)